ICMI 2015

T.105 Role of SMAD7 in the intestinal epithelium for gut homeostasis and tumor development

Thursday, July 16, 2015
Grand Hall and Gallery, Ground Floor & 1st Floor (Maritim Hotel)
Evelyn Schneider , Medical Clinic 1, Friedrich-Alexander-University, Erlangen, Germany
Nadine Wittkopf , Medical Clinic 1, Friedrich-Alexander-University, Erlangen, Germany
Markus F. Neurath , Medical Clinic 1, Friedrich-Alexander-University, Erlangen, Germany
Christoph Becker , Medical Clinic 1, Friedrich-Alexander-University, Erlangen, Germany
Besides the function as an inhibitor of the TGF-ß signaling pathway, polymorphisms of SMAD7 play a crucial role in increasing the risk for the development of colon cancer.  In order to analyze the role of epithelial Smad7for colon cancer development we generated mice with a conditional knockout for Smad7 in intestinal epithelial cells (Smad7ΔIEC). Smad7ΔIEC mice were born at mendelian ratio and did not show defects in the postnatal development of the gut. We next subjected Smad7ΔIEC mice to an experimental model of colitis associated cancer (AOM-DSS model). Surprisingly, Smad7ΔIEC mice developed fewer tumors in comparison to the control group (Smad7fl.).  To investigate whether the decreased number of colon tumors in Smad7ΔIEC mice was dependent on colitis in the AOM-DSS model, we next used a sporadic tumor mouse model (APCmin). Comparison of APCmin+/- Smad7ΔIEC and control mice (APCmin+/-) revealed that APCmin+/- Smad7ΔIEC mice not only showed a higher survival rate but also a reduced number of tumors. These findings strongly support our hypothesis that Smad7 plays a crucial role in the development of colon tumors independently from inflammation.